{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:32:58Z","timestamp":1774654378468,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["No.LGF22H220006"],"award-info":[{"award-number":["No.LGF22H220006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Health Science and Technology Project of Zhejiang Province","award":["2021KY549"],"award-info":[{"award-number":["2021KY549"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01884-x","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T10:35:35Z","timestamp":1756118135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of biparameter and multiparameter MRI in detection of clinically significant prostate cancer across PSA stratifications"],"prefix":"10.1186","volume":"25","author":[{"given":"Pengfei","family":"Jin","sequence":"first","affiliation":[]},{"given":"Zhenwei","family":"Ding","sequence":"additional","affiliation":[]},{"given":"Fawei","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[]},{"given":"Yitao","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Ge","family":"Song","sequence":"additional","affiliation":[]},{"given":"Liqin","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"1884_CR1","doi-asserted-by":"publisher","unstructured":"Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in china, 2022. J Natl Cancer Cent. 2024;4(1). https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","DOI":"10.1016\/j.jncc.2024.01.006"},{"issue":"1","key":"1884_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","volume":"17","author":"A Stabile","year":"2020","unstructured":"Stabile A, Giganti F, Rosenkrantz AB, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020;17(1):41\u201361. https:\/\/doi.org\/10.1038\/s41585-019-0212-4.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"1884_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13244-023-01421-w","volume":"14","author":"Z Sun","year":"2023","unstructured":"Sun Z, Wang K, Kong Z, et al. A multicenter study of artificial intelligence-aided software for detecting visible clinically significant prostate cancer on MpMRI. Insights Imaging. 2023;14(1):72. https:\/\/doi.org\/10.1186\/s13244-023-01421-w.","journal-title":"Insights Imaging"},{"issue":"4","key":"1884_CR4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","volume":"22","author":"JO Barentsz","year":"2012","unstructured":"Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746\u201357. https:\/\/doi.org\/10.1007\/s00330-011-2377-y.","journal-title":"Eur Radiol"},{"key":"1884_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.052","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, et al. Eur Urol. 2016;69(1):16\u201340. https:\/\/doi.org\/10.1016\/j.eururo.2015.08.052. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2."},{"key":"1884_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, et al. Eur Urol. 2019;76(3):340\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2."},{"issue":"12","key":"1884_CR7","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.ejrad.2016.10.009","volume":"85","author":"A Stanzione","year":"2016","unstructured":"Stanzione A, Imbriaco M, Cocozza S, et al. Biparametric 3T magnetic resonance imaging for prostatic cancer detection in a biopsy-na\u00efve patient population: a further improvement of PI-RADS v2? Eur J Radiol. 2016;85(12):2269\u201374. https:\/\/doi.org\/10.1016\/j.ejrad.2016.10.009.","journal-title":"Eur J Radiol"},{"issue":"3","key":"1884_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiol.2017161316","volume":"285","author":"MD Greer","year":"2017","unstructured":"Greer MD, Shih JH, Lay N, Turkbey B, et al. Validation of the dominant sequence paradigm and role of dynamic Contrast-enhanced imaging in PI-RADS version 2. Radiology. 2017;285(3):859\u201369. https:\/\/doi.org\/10.1148\/radiol.2017161316.","journal-title":"Radiology"},{"issue":"5","key":"1884_CR9","doi-asserted-by":"publisher","first-page":"W226","DOI":"10.2214\/AJR.18.19880","volume":"211","author":"S Woo","year":"2018","unstructured":"Woo S, Suh CH, Kim SY, et al. Head-to-Head comparison between biparametric and multiparametric MRI for the diagnosis of prostate cancer: A systematic review and Meta-Analysis. AJR Am J Roentgenol. 2018;211(5):W226\u201341. https:\/\/doi.org\/10.2214\/AJR.18.19880.","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"1884_CR10","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00345-022-041201","volume":"40","author":"WM Thaiss","year":"2022","unstructured":"Thaiss WM, Moser S, Hepp T, et al. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy. World J Urol. 2022;40(10):2431\u20138. https:\/\/doi.org\/10.1007\/s00345-022-041201.","journal-title":"World J Urol"},{"issue":"5","key":"1884_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2214\/AJR.21.26569","volume":"218","author":"JM Gan","year":"2022","unstructured":"Gan JM, Kikano EG, Smith DA, et al. Clinically significant prostate cancer detection after a negative prebiopsy MRI examination: comparison of biparametric versus multiparametric MRI. AJR Am J Roentgenol. 2022;218(5):859\u201366. https:\/\/doi.org\/10.2214\/AJR.21.26569.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"1884_CR12","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00261-019-01934-3","volume":"44","author":"M Gatti","year":"2019","unstructured":"Gatti M, Faletti R, Calleris G, et al. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI). Abdom Radiol (NY). 2019;44(5):1883\u201393. https:\/\/doi.org\/10.1007\/s00261-019-01934-3.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"1884_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.21873\/anticanres.16163","volume":"43","author":"M Scialpi","year":"2023","unstructured":"Scialpi M, Martorana E, Scialpi P, et al. S-PI-RADS and PI-RRADS for biparametric MRI in the detection of prostate cancer and Post-treatment local recurrence. Anticancer Res. 2023;43(1):297\u2013303. https:\/\/doi.org\/10.21873\/anticanres.16163.","journal-title":"Anticancer Res"},{"issue":"9959","key":"1884_CR14","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","volume":"384","author":"FH Schr\u00f6der","year":"2014","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European randomised study of screening for prostate cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60525-0.","journal-title":"Lancet"},{"issue":"4","key":"1884_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cdp.2008.12.004","volume":"32","author":"J Philip","year":"2009","unstructured":"Philip J, Manikandan R, Javl\u00e9 P, et al. Prostate cancer diagnosis: should patients with prostate specific antigen\u2009>\u200910ng\/mL have stratified prostate biopsy protocols? Cancer Detect Prev. 2009;32(4):314\u20138. https:\/\/doi.org\/10.1016\/j.cdp.2008.12.004.","journal-title":"Cancer Detect Prev"},{"issue":"4","key":"1884_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.diii.2020.01.014","volume":"101","author":"C Han","year":"2020","unstructured":"Han C, Liu S, Qin XB, et al. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4\u2009~\u200910ng\/mL: biparametric versus multiparametric MRI. Diagn Interv Imaging. 2020;101(4):235\u201344. https:\/\/doi.org\/10.1016\/j.diii.2020.01.014.","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"1884_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1148\/radiol.2017170129","volume":"285","author":"CK Kuhl","year":"2017","unstructured":"Kuhl CK, Bruhn R, Kr\u00e4mer N, et al. Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen. Radiology. 2017;285(2):493\u2013505. https:\/\/doi.org\/10.1148\/radiol.2017170129.","journal-title":"Radiology"},{"issue":"1","key":"1884_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.crad.2016.09.011","volume":"72","author":"P De Visschere","year":"2017","unstructured":"De Visschere P, Lumen N, Ost P, et al. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol. 2017;72(1):23\u201332. https:\/\/doi.org\/10.1016\/j.crad.2016.09.011.","journal-title":"Clin Radiol"},{"issue":"4","key":"1884_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","volume":"41","author":"Epstein","year":"2017","unstructured":"Epstein JI, Amin MB, Reuter VE, et al. Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2017;41(4):e1\u20137. https:\/\/doi.org\/10.1097\/PAS.0000000000000820.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1884_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jmri.27283","volume":"53","author":"T Tamada","year":"2021","unstructured":"Tamada T, Kido A, Yamamoto A, et al. Comparison of biparametric and multiparametric MRI for clinically significant prostate cancer detection with PI-RADS version 2.1. J Magn Reson Imaging. 2021;53(1):283\u201391. https:\/\/doi.org\/10.1002\/jmri.27283.","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"1884_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.juro.2017.07.011","volume":"198","author":"SC Druskin","year":"2017","unstructured":"Druskin SC, Ward R, Purysko AS, et al. Dynamic contrast enhanced magnetic resonance imaging improves classification of prostate lesions: A study of pathological outcomes on targeted prostate biopsy. J Urol. 2017;198(6):1301\u20138. https:\/\/doi.org\/10.1016\/j.juro.2017.07.011.","journal-title":"J Urol"},{"issue":"1","key":"1884_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40644-019-0274-9","volume":"19","author":"L Xu","year":"2019","unstructured":"Xu L, Zhang G, Shi B, et al. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer. Cancer Imaging. 2019;19(1):90. https:\/\/doi.org\/10.1186\/s40644-019-0274-9.","journal-title":"Cancer Imaging"},{"issue":"7","key":"1884_CR23","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1007\/s00330-020-06782-0","volume":"30","author":"JP Zawaideh","year":"2020","unstructured":"Zawaideh JP, Sala E, Shaida N, et al. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice. Eur Radiol. 2020;30(7):4039\u201349. https:\/\/doi.org\/10.1007\/s00330-020-06782-0.","journal-title":"Eur Radiol"},{"key":"1884_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejrad.2018.01.028","volume":"101","author":"E Di Campli","year":"2018","unstructured":"Di Campli E, Delli Pizzi A, Seccia B, et al. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: comparison between readers with different experience. Eur J Radiol. 2018;101:17\u201323. https:\/\/doi.org\/10.1016\/j.ejrad.2018.01.028.","journal-title":"Eur J Radiol"},{"issue":"6","key":"1884_CR25","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.4103\/jcrt.JCRT_1313_20","volume":"18","author":"M Mahajan","year":"2022","unstructured":"Mahajan M, Gupta V, Gupta P, et al. Evaluation of clinically significant prostate cancer using biparametric magnetic resonance imaging: an evolving concept. J Cancer Res Ther. 2022;18(6):1640\u20135. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1313_20.","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"1884_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00261-022-03750-8","volume":"48","author":"J Song","year":"2023","unstructured":"Song J, Zhao C, Zhang F, et al. The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified BpMRI versus standard MpMRI. Abdom Radiol (NY). 2023;48(2):704\u201312. https:\/\/doi.org\/10.1007\/s00261-022-03750-8.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"1884_CR27","doi-asserted-by":"publisher","first-page":"W166","DOI":"10.2214\/AJR.17.19253","volume":"211","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Oh YT, Jung DC, et al. Combined analysis of biparametric MRI and prostate-Specific antigen density: role in the prebiopsy diagnosis of Gleason score 7 or greater prostate cancer. AJR Am J Roentgenol. 2018;211(3):W166\u201372. https:\/\/doi.org\/10.2214\/AJR.17.19253.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"1884_CR28","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/jmri.27841","volume":"55","author":"MJ Kim","year":"2022","unstructured":"Kim MJ, Park SY. Biparametric magnetic resonance Imaging-Derived nomogram to detect clinically significant prostate cancer by targeted biopsy for index lesion. J Magn Reson Imaging. 2022;55(4):1226\u201333. https:\/\/doi.org\/10.1002\/jmri.27841.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"1884_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2017.02.021","volume":"73","author":"W Venderink","year":"2018","unstructured":"Venderink W, van Luijtelaar A, Bomers JGR, et al. Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer. Eur Urol. 2018;73(3):353\u201360. https:\/\/doi.org\/10.1016\/j.eururo.2017.02.021.","journal-title":"Eur Urol"},{"issue":"4","key":"1884_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2214\/AJR.18.20498","volume":"212","author":"MH Choi","year":"2019","unstructured":"Choi MH, Kim CK, Lee YJ, et al. Prebiopsy biparametric MRI for clinically significant prostate cancer detection with PI-RADS version 2: A multicenter study. AJR Am J Roentgenol. 2019;212(4):839\u201346. https:\/\/doi.org\/10.2214\/AJR.18.20498.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"1884_CR31","doi-asserted-by":"publisher","first-page":"e221309","DOI":"10.1148\/radiol.221309","volume":"307","author":"EC Yilmaz","year":"2023","unstructured":"Yilmaz EC, Shih JH, Belue MJ, et al. Prospective evaluation of PI-RADS version 2.1 for prostate cancer detection and investigation of multiparametric MRI-derived markers. Radiology. 2023;307(4):e221309. https:\/\/doi.org\/10.1148\/radiol.221309.","journal-title":"Radiology"},{"issue":"1","key":"1884_CR32","doi-asserted-by":"publisher","first-page":"e240041","DOI":"10.1148\/radiol.240041","volume":"313","author":"DD Yang","year":"2024","unstructured":"Yang DD, Lee LK, Tsui JMG, et al. AI-derived tumor volume from multiparametric MRI and outcomes in localized prostate cancer. Radiology. 2024;313(1):e240041. https:\/\/doi.org\/10.1148\/radiol.240041.","journal-title":"Radiology"},{"issue":"2","key":"1884_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000365697","volume":"8","author":"H Liddell","year":"2015","unstructured":"Liddell H, Jyoti R, Haxhimolla HZ. mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate Cancer - A retrospective review of 92 biopsied PIRADS 3 lesions. Curr Urol. 2015;8(2):96\u2013100. https:\/\/doi.org\/10.1159\/000365697.","journal-title":"Curr Urol"},{"key":"1884_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clinimag.2021.06.024","volume":"88","author":"G Wang","year":"2022","unstructured":"Wang G, Yu G, Chen J, et al. Can high b-value 3.0 T biparametric MRI with the simplified prostate image reporting and data system (S-PI-RADS) be used in biopsy-na\u00efve men? Clin Imaging. 2022;88:80\u20136. https:\/\/doi.org\/10.1016\/j.clinimag.2021.06.024.","journal-title":"Clin Imaging"},{"key":"1884_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clinimag.2022.11.013","volume":"94","author":"M Scialpi","year":"2023","unstructured":"Scialpi M, Martorana E, Torre R, et al. Index lesion detection in multifocal prostate cancer: simplified PI-RADS biparametric MRI vs PI-RADS v2.1 multiparametric MRI. Clin Imaging. 2023;94:108\u201315. https:\/\/doi.org\/10.1016\/j.clinimag.2022.11.013.","journal-title":"Clin Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01884-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:10:31Z","timestamp":1756390231000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01884-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1884"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01884-x","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.eururo.2015.08.052","asserted-by":"subject"},{"id-type":"doi","id":"10.1016\/j.eururo.2019.02.033","asserted-by":"subject"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approval from the ethics committees of Zhejiang Cancer Hospital and exemption from the requirement for written informed consent (IRB-2024-432). All procedures in studies with human participants complied with the ethical standards of the institutional\/national research committee and the 1964 Helsinki Declaration and its amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}